Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Legend Biotech Corporation Sponsored ADR (LEGN) had Return on Equity of -5.61% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$305.10M |
|
$-54.30M |
|
$175.90M |
|
$129.20M |
|
$360.00M |
|
$-54.90M |
|
$1.80M |
|
$-53.10M |
|
$-53.10M |
|
$-54.30M |
|
$-54.30M |
|
$-54.30M |
|
$-54.30M |
|
$-54.90M |
|
$-39.30M |
|
185.10M |
|
185.10M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$1.08B |
|
$121.40M |
|
$514.00M |
|
$1.60B |
|
$509.10M |
|
-- |
|
$119.90M |
|
$629.00M |
|
$967.70M |
|
$967.70M |
|
$967.70M |
|
185.74M |
|
| Cash Flow Statement Financials | |
$-85.10M |
|
$-168.00M |
|
$-1.20M |
|
$901.90M |
|
$646.40M |
|
$-255.50M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
42.35% |
|
-17.99% |
|
-17.99% |
|
-- |
|
-17.40% |
|
-17.80% |
|
$-92.60M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
4.74 |
|
179.47 |
|
0.50 |
|
|
Return on Equity |
-5.61% |
-5.61% |
|
-3.40% |
|
-5.61% |
|
$5.21 |
|
$-0.50 |
|
$-0.46 |
|